Trials that use: Logistic regression
New to this method? Read the tutorial →
5,900 results
- TIDEIndependent statistical analysis of Thiazolidinedione Intervention With Vitamin D Evaluation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00879970).
- TIDE-asthmaIndependent statistical analysis of Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TIL Therapy in Combination With Checkpoint Inhibitors for Metastatic Ovarian Cancer: Complete Statistical AnalysisIndependent statistical analysis of TIL Therapy in Combination With Checkpoint Inhibitors for Metastatic Ovarian Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Time-restricted Eating in Cancer Survivorship: A Single-arm Feasibility Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Time-restricted Eating in Cancer Survivorship: A Single-arm Feasibility Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04243512).
- Timing of Antibiotic Prophylaxis for Cesarean Deliveries: Complete Statistical AnalysisIndependent statistical analysis of Timing of Antibiotic Prophylaxis for Cesarean Deliveries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00805545).
- Timing of B and O Suppositories to Help Relieve Post-operative Bladder Spasms: Complete Statistical AnalysisIndependent statistical analysis of Timing of B and O Suppositories to Help Relieve Post-operative Bladder Spasms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- TINTINIndependent statistical analysis of Clinical Trial Investigating the Combination Therapy With Luminor DCB and iVolution Stent in TASC C and D Femoropopliteal Lesions: primary endpoint results, effect estimate with confidence interval, sample-size…
- Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial: Complete Statistical AnalysisIndependent statistical analysis of Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial: primary endpoint results, effect estimate with confidence…
- Tipifarnib in Subjects With Myelodysplastic Syndromes: Complete Statistical AnalysisIndependent statistical analysis of Tipifarnib in Subjects With Myelodysplastic Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02779777).
- Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00082888).
- Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients: Complete Statistical AnalysisIndependent statistical analysis of Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00530920).
- TIRCON-EXTIndependent statistical analysis of Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02174848).
- Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections: Complete Statistical AnalysisIndependent statistical analysis of Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TitAINIndependent statistical analysis of A Placebo-controlled Phase 2 Trial to Investigate the Safety and Efficacy of Secukinumab in Giant Cell Arteritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- TITREIndependent statistical analysis of Influenza Vaccine Dose-Response in Infants and Toddlers: Immunogenicity and Reactogenicity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00710866).
- TK008Independent statistical analysis of Efficacy Study on the Strategy of HSV-Tk Engineering Donor Lymphocytes to Treat Patients With High Risk Acute Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- TL011 in Severe, Active Rheumatoid Arthritis Patients: Complete Statistical AnalysisIndependent statistical analysis of TL011 in Severe, Active Rheumatoid Arthritis Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01123070).
- TMC114IFD3001 – Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir(Rtv) in HIV1 Infected Adults, Adolescents and Children Aged 3 Years or Above and Coming From Previous Company Sponsored Studies With DRV: Complete Statistical AnalysisIndependent statistical analysis of TMC114IFD3001 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir(Rtv) in HIV1 Infected Adults, Adolescents and Children Aged 3 Years or Above and Coming From Previous Company…
- TMH PilotIndependent statistical analysis of Family Telemental Health Intervention for Veterans With Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03116464).
- TMZ + Olaparib for MGMT Hypermethylated Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of TMZ + Olaparib for MGMT Hypermethylated Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04166435).
- TN07Independent statistical analysis of Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- To Assess Continued Safety of and Adherence to the Dapivirine (25 mg) Vaginal Ring-004 in Healthy, HIV-negative Women: Complete Statistical AnalysisIndependent statistical analysis of To Assess Continued Safety of and Adherence to the Dapivirine (25 mg) Vaginal Ring-004 in Healthy, HIV-negative Women: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer: Complete Statistical AnalysisIndependent statistical analysis of To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer: primary endpoint…
- To Assess Safety, Tolerability and Pharmacokinetics of BI 416970 in Healthy Male Volunteers: Complete Statistical AnalysisIndependent statistical analysis of To Assess Safety, Tolerability and Pharmacokinetics of BI 416970 in Healthy Male Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Patients With Hepatic Impairment and Healthy Subjects: Complete Statistical AnalysisIndependent statistical analysis of To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Patients With Hepatic Impairment and Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- To Compare Safety and Efficacy of Perrigo’s Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis: Complete Statistical AnalysisIndependent statistical analysis of To Compare Safety and Efficacy of Perrigo's Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis: primary endpoint results, effect estimate with confidence interval,…
- To Evaluate Safety, Pharmacokinetics and Pharmacodynamics of MEDI6012 in Subjects With Stable Coronary Artery Disease: Complete Statistical AnalysisIndependent statistical analysis of To Evaluate Safety, Pharmacokinetics and Pharmacodynamics of MEDI6012 in Subjects With Stable Coronary Artery Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- To Evaluate The Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures: Complete Statistical AnalysisIndependent statistical analysis of To Evaluate The Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures: primary endpoint results, effect estimate with confidence interval, sample-size…
- To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313): Complete Statistical AnalysisIndependent statistical analysis of To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- To Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1467335 Following Multiple Dose Administration Over 28 Days: Complete Statistical AnalysisIndependent statistical analysis of To Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1467335 Following Multiple Dose Administration Over 28 Days: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- To Investigate the Relative Efficacy of Terbutaline Turbuhaler® and Salbutamol Pressurized Metered Dose Inhaler (pMDI) a Single Blind Study: Complete Statistical AnalysisIndependent statistical analysis of To Investigate the Relative Efficacy of Terbutaline Turbuhaler® and Salbutamol Pressurized Metered Dose Inhaler (pMDI) a Single Blind Study: primary endpoint results, effect estimate with confidence interval, sample-size…
- To Show the Safety and Effectiveness of the Demetech Barbed Polydioxanone (PDO) Suture: Complete Statistical AnalysisIndependent statistical analysis of To Show the Safety and Effectiveness of the Demetech Barbed Polydioxanone (PDO) Suture: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- TOBA II BTKIndependent statistical analysis of Tack Optimized Balloon Angioplasty Study of the Tack Endovascular System® in Below the Knee Arteries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Tobacco Cessation at FDNY: Complete Statistical AnalysisIndependent statistical analysis of Tobacco Cessation at FDNY: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05997225).
- Tobacco Use Treatment in Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Tobacco Use Treatment in Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03482583).
- TOBY (TOtal Body hYpothermia): a Study of Treatment for Perinatal Asphyxia: Complete Statistical AnalysisIndependent statistical analysis of TOBY (TOtal Body hYpothermia): a Study of Treatment for Perinatal Asphyxia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Tocilizumab for Patients With Giant Cell Arteritis: Complete Statistical AnalysisIndependent statistical analysis of Tocilizumab for Patients With Giant Cell Arteritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01450137).
- Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Tocilizumab for the Treatment of Behcet’s Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Tocilizumab for the Treatment of Behcet's Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01693653).
- Tofacitinib for the Treatment of Alopecia Areata and Its Variants: Complete Statistical AnalysisIndependent statistical analysis of Tofacitinib for the Treatment of Alopecia Areata and Its Variants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02312882).
- Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis: Complete Statistical AnalysisIndependent statistical analysis of Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03793439).
- Tolerability Comparison Between Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin: Complete Statistical AnalysisIndependent statistical analysis of Tolerability Comparison Between Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Tolerability of Bimatoprost 0.01% vs Latanoprost Eye Drops: Complete Statistical AnalysisIndependent statistical analysis of Tolerability of Bimatoprost 0.01% vs Latanoprost Eye Drops: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02138461).
- Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation): Complete Statistical AnalysisIndependent statistical analysis of Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Tolvaptan for Ascites in Cirrhotic Patients: Complete Statistical AnalysisIndependent statistical analysis of Tolvaptan for Ascites in Cirrhotic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01292304).
- TOMOIndependent statistical analysis of Pilot Study Comparing Diagnostic Imaging Versus Tomosynthesis in Detection of Hip, Wrist or Tibia Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- TOP 1501Independent statistical analysis of Neoadjuvant Pembrolizumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02818920).
- TOP1201 IPIIndependent statistical analysis of Evaluation of Circulating T Cells and Tumor Infiltrating Lymphocytes (TILs) During / After Pre-Surgery Chemotherapy in Non-Small Cell Lung Cancer (NSCLC): primary endpoint results, effect estimate with confidence…
- TOPAZIndependent statistical analysis of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.: primary endpoint results, effect estimate with confidence interval, sample-size…
- TOPAZ-IIndependent statistical analysis of A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV)…